Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTecWallstreetcn·Mar 25 at 08:35 PM510660+0.86%603538+3.04%
CRO concept stocks fluctuated and strengthened, with Fushine and Menovo both hitting the daily limit, Kingchem rising more than 10%, and Biocytogen, BHC, and ChemPartner following suitWallstreetcn·Mar 23 at 08:42 PM688796-1.51%300497+0.67%
BHC: The net profit for the third quarter was 7.1908 million yuan, a year-on-year increase of 456.45%Zhitong·Oct 27, 2025 at 05:27 AM600721+2.63%
The concept of innovative drugs rebounds, BHC and HWHG hit the limit upZhitong·Sep 2, 2025 at 09:53 PM600721+2.63%600079-0.17%
BHC released its performance for the first half of the year, with a net profit attributable to the parent company of 25.4834 million yuan, a year-on-year increase of 12.45%Zhitong·Aug 21, 2025 at 04:19 AM600721+2.63%
The concept of weight loss drugs continues to strengthen, BHC hits the daily limitZhitong·Aug 17, 2025 at 08:59 PM600721+2.63%
BHC released its first-quarter performance, with a net profit attributable to the parent company of 20.7209 million yuan, a year-on-year increase of 0.28%Zhitong·Apr 25, 2025 at 03:26 AM600721+2.63%
The pharmaceutical sector strengthens with multiple stocks rising over 10%Zhitong·Apr 17, 2025 at 08:41 PM600721+2.63%301509+2.63%
The pharmaceutical sector rises, with multiple stocks hitting the daily limitZhitong·Mar 27, 2025 at 09:03 PM600721+2.63%000953+2.65%
The CRO concept sector has seen a surge, with BHC and HC CHEMICAL hitting the limit upZhitong·Mar 27, 2025 at 09:01 PM600721+2.63%000953+2.65%
The innovative drug concept is repeatedly active, and BHC has hit the daily limitZhitong·Mar 27, 2025 at 08:53 PM688197+1.26%688068+4.55%
BHC released its 2024 annual performance, with a net profit attributable to the parent company of 41.479 million yuan, a year-on-year increase of 219.75%Zhitong·Mar 11, 2025 at 09:04 AM600721+2.63%
Five departments: Strengthen and improve antitrust law enforcement in the consumer market to combat exclusionary and restrictive competition behaviors in the fields of pharmaceuticals, public utilities, and automobilesWallstreetcn·Feb 19, 2025 at 02:34 AM002727-9.00%600721+2.63%
Guotai Junan Securities: The high enthusiasm for AI applications in medicine is worth laying out; traditional mainline quarterly reports may welcome a reversalZhitong·Feb 10, 2025 at 02:11 AM600721+2.63%002727-9.00%
